Nicole White
Corporate Officer/Principal bij ASSEMBLY BIOSCIENCES, INC.
Vermogen: 174 014 $ op 30-04-2024
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Jason Okazaki | M | 48 | 4 jaar | |
| John McHutchison | M | 66 | 14 jaar | |
| William Ringo | M | 78 | 10 jaar | |
| Bryan Giraudo | M | 48 | 6 jaar | |
| Susan Mahony | M | 59 | 7 jaar | |
| Gina Consylman | F | 52 | 4 jaar | |
| Jeanette Bjorkquist | F | - | 5 jaar | |
| John O. Gunderson | M | - | 2 jaar | |
| Lisa Johnson-Pratt | M | 60 | 3 jaar | |
| Renée Galá | F | 52 | 6 jaar | |
| Michael Houghton | M | 73 | 3 jaar | |
| Russell Cox | M | 60 | 6 jaar | |
| Anthony Altig | M | 68 | 12 jaar | |
| Chan Beals | M | - |
Abide Therapeutics, Inc.
 Abide Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Abide Therapeutics, Inc. develops medicines that target serine hydrolases. Its approach is to selectively block serine hydrolases, potentially expanding this class of commercially validated enzymes as targets in a range of indications. The firm has a technology platform that exploits a chemoproteomics approach to selectively target serine hydrolases and rapidly identify target lead pairs. The company was founded by Alan B. Ezekowitz, Dale Boger, John Kennedy Clarke, Benjamin F. Cravatt, Todd Jones, Keith F. Lenden, and Paul R. Schimmel in 2011 and is headquartered in San Diego, CA. | 8 jaar |
| Jennifer A. Troia | F | - | 7 jaar | |
| Tomas Cihlar | M | 57 | 1 jaar | |
| Linda Higgins | M | 62 | 14 jaar | |
| William Delaney | M | 52 | 4 jaar | |
| Shannon Ryan | F | - | - | |
| Anuj Gaggar | M | 46 | 1 jaar | |
| Robert Cook | M | 65 | 12 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Uri Lopatin | M | 52 | 17 jaar | |
| Michael Samar | M | 51 | 5 jaar | |
| Thomas Russo | M | 52 | 9 jaar | |
| Gordon Earle Moore | M | 95 | 17 jaar | |
| Monica Tellado | F | 51 | 9 jaar | |
| Myron Holubiak | M | 77 | 12 jaar | |
| Josh Bilenker | M | 52 | 5 jaar | |
| Laura Carter | M | 57 | 4 jaar | |
| Kevin Lofton | M | 69 | 15 jaar | |
| David Dornan | M | 46 | 5 jaar | |
| Wen Kai Xiang | M | - | - | |
| Otello Stampacchia | M | 55 | 1 jaar | |
| James M. Denny | M | 91 | 17 jaar | |
| Richard DiMarchi | M | 71 | 9 jaar | |
| Per Wold-Olsen | M | 76 | - | |
| Alan J. Lewis | M | 78 | 5 jaar | |
| Paul A. Berg | M | 97 | 13 jaar | |
| Mani Subramanian | M | - | 9 jaar | |
| Susannah Cantrell | M | - | 8 jaar | |
| Diana Brainard | M | 53 | 6 jaar | |
| Roger Dansey | M | 67 | 1 jaar | |
| Arvinder Dhalla | M | - | 6 jaar | |
| Carla Fiankan | F | - | 7 jaar | |
| Shao Lee Lin | M | 57 | 3 jaar | |
| Stephen Cheng | M | - | 7 jaar | |
| Matthew Lang | M | 48 | 8 jaar | |
| Erik Emerson | M | 53 | 3 jaar | |
| Wayne Godfrey | M | 63 | 3 jaar | |
| Dennis D. Self | M | 59 | 2 jaar | |
| Kenneth Lynard | M | 56 | 4 jaar | |
| Kenneth Lock | M | 50 | 6 jaar | |
| Rajesh Krishnan | M | 51 | 5 jaar | |
| Hunter Gillies | M | 58 | 5 jaar | |
| Yuan Xu | M | 56 | 1 jaar | |
| John Sundy | M | 62 | 6 jaar | |
| Erin Quirk | M | 53 | 8 jaar | |
| Charles Winter | M | - | 4 jaar | |
| Ron Sarkar | M | - | 5 jaar | |
| Christophe Quéva | M | 57 | 3 jaar | |
| Rolf Carlsson | M | - | 2 jaar | |
| Marni Kottle | F | - | 8 jaar | |
| William Guyer | M | 56 | 6 jaar | |
| Elvia Cowan | F | 51 | 3 jaar | |
| Elizabeth Ann Fagan | M | 74 | 2 jaar | |
| Ashraf Amanullah | M | 56 | 4 jaar | |
| Smital Shah | F | 48 | 2 jaar | |
| Qing Qing Yi | M | 52 | - | |
| Philip T. Sager | M | 68 | 1 jaar | |
| Anthony D. Caracciolo | M | 68 | 13 jaar | |
| Kenneth F. Boehm | M | - | 11 jaar | |
| Robert Nelsen | M | 60 | 1 jaar | |
| Louis Lange | M | 72 | - | |
| Helen Kim | F | 61 | 2 jaar | |
| Sapna R. Srivastava | M | 53 |
Abide Therapeutics, Inc.
Abide Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Abide Therapeutics, Inc. develops medicines that target serine hydrolases. Its approach is to selectively block serine hydrolases, potentially expanding this class of commercially validated enzymes as targets in a range of indications. The firm has a technology platform that exploits a chemoproteomics approach to selectively target serine hydrolases and rapidly identify target lead pairs. The company was founded by Alan B. Ezekowitz, Dale Boger, John Kennedy Clarke, Benjamin F. Cravatt, Todd Jones, Keith F. Lenden, and Paul R. Schimmel in 2011 and is headquartered in San Diego, CA. | 2 jaar |
| Kevin B. Young | M | 66 | 10 jaar | |
| Muzammil Mansuri | M | 70 | 6 jaar | |
| Alan Montgomery | M | 70 | 5 jaar | |
| Stan Blackburn | M | 68 |
Abide Therapeutics, Inc.
Abide Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Abide Therapeutics, Inc. develops medicines that target serine hydrolases. Its approach is to selectively block serine hydrolases, potentially expanding this class of commercially validated enzymes as targets in a range of indications. The firm has a technology platform that exploits a chemoproteomics approach to selectively target serine hydrolases and rapidly identify target lead pairs. The company was founded by Alan B. Ezekowitz, Dale Boger, John Kennedy Clarke, Benjamin F. Cravatt, Todd Jones, Keith F. Lenden, and Paul R. Schimmel in 2011 and is headquartered in San Diego, CA. | - |
| Roy Baynes | M | 69 | 1 jaar | |
| Susan T. Hubbard | F | - | 23 jaar | |
| Langdon L. Miller | M | 70 | 2 jaar | |
| David Gollaher | M | 74 | 4 jaar | |
| Scott Ogg | M | 57 | 2 jaar | |
| Tse Li Yang | F | 51 | 12 jaar | |
| Christopher Griffith | M | 47 | 5 jaar | |
| Phillip Gutry | M | 50 | 5 jaar | |
| Jakob Dupont | M | 58 | 2 jaar | |
| Maria Fardis | M | 56 | 11 jaar | |
| Robert Janssen | M | 70 | 2 jaar | |
| Jung Choi | F | 54 | 8 jaar | |
| Philippe C. Bishop | M | 59 | 2 jaar | |
| Jeffrey Hessekiel | M | 55 | 10 jaar | |
| Craig S. Gibbs | M | 61 | 21 jaar | |
| Noreen Henig | M | 59 | 6 jaar | |
| William T. Symonds | M | 56 | 2 jaar | |
| Michael Sofia | M | 66 | - | |
| Christopher Senner | M | 56 | 5 jaar | |
| Ramin Farzaneh-Far | M | 47 | 3 jaar | |
| Pawel Trawkowski | M | - | - |
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Verenigde Staten | 100 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Nicole White
- Persoonlijk netwerk
